D'adamio S - Search Results

1

Galluzzo M, D'adamio S, Bianchi L, Talamonti M. Galluzzo M, et al. Expert Opin Biol Ther. 2017 May;17(5):645-657. doi: 10.1080/14712598.2017.1304537. Epub 2017 Mar 17. Expert Opin Biol Ther. 2017. PMID: 28271735 Review.

2

The Role of Pharmacogenetics in Chronic Plaque Psoriasis: Update of the Literature.

Talamonti M, D'Adamio S, Bianchi L, Galluzzo M. Talamonti M, et al. Mol Diagn Ther. 2017 Oct;21(5):467-480. doi: 10.1007/s40291-017-0274-z. Mol Diagn Ther. 2017. PMID: 28374122 Review.

3

Effect of anti IL-12/23 on body composition: results of bioelectrical impedance analysis in Caucasian psoriatic patients.

Galluzzo M, D'Adamio S, Pastorino R, Andreoli A, Servoli S, Bianchi L, Talamonti M. Galluzzo M, et al. Expert Opin Biol Ther. 2018 Mar;18(3):229-235. doi: 10.1080/14712598.2018.1419183. Epub 2017 Dec 22. Expert Opin Biol Ther. 2018. PMID: 29252034

4

Psoriasis in pregnancy: case series and literature review of data concerning exposure during pregnancy to ustekinumab.

Galluzzo M, D'Adamio S, Bianchi L, Talamonti M. Galluzzo M, et al. J Dermatolog Treat. 2019 Feb;30(1):40-44. doi: 10.1080/09546634.2018.1468066. Epub 2018 May 3. J Dermatolog Treat. 2019. PMID: 29676599 Review.

5

Secukinumab in moderate-to-severe plaque psoriasis: a multi-center, retrospective, real-life study up to 52 weeks observation.

Galluzzo M, Talamonti M, De Simone C, D'Adamio S, Moretta G, Tambone S, Caldarola G, Fargnoli MC, Peris K, Bianchi L. Galluzzo M, et al. Expert Opin Biol Ther. 2018 Jul;18(7):727-735. doi: 10.1080/14712598.2018.1481503. Epub 2018 Jun 6. Expert Opin Biol Ther. 2018. PMID: 29798698

6

Treating a Multidrug-Resistant Psoriatic HLA-C*18:01 Allele Carrier with Combination Ustekinumab Apremilast Therapy.

Galluzzo M, D'Adamio S, Campione E, Bianchi L, Talamonti M. Galluzzo M, et al. Mol Diagn Ther. 2018 Dec;22(6):717-721. doi: 10.1007/s40291-018-0354-8. Mol Diagn Ther. 2018. PMID: 30076588

7

Biologic therapy for acrodermatitis continua of Hallopeau: Successful treatment with secukinumab and review of the literature.

Galluzzo M, D'Adamio S, Teoli M, Bianchi L, Talamonti M. Galluzzo M, et al. Dermatol Ther. 2019 May;32(3):e12899. doi: 10.1111/dth.12899. Epub 2019 Apr 29. Dermatol Ther. 2019. PMID: 30969010 Free PMC article. Review.

8

In which patients the best efficacy of secukinumab? Update of a real-life analysis after 136 weeks of treatment with secukinumab in moderate-to-severe plaque psoriasis.

Galluzzo M, D'Adamio S, Silvaggio D, Lombardo P, Bianchi L, Talamonti M. Galluzzo M, et al. Among authors: d adamio s. Expert Opin Biol Ther. 2020 Feb;20(2):173-182. doi: 10.1080/14712598.2020.1708897. Epub 2019 Dec 27. Expert Opin Biol Ther. 2020. PMID: 31880166

9

Tofacitinib for the treatment of psoriasis.

Galluzzo M, D'Adamio S, Servoli S, Bianchi L, Chimenti S, Talamonti M. Galluzzo M, et al. Expert Opin Pharmacother. 2016 Jul;17(10):1421-33. doi: 10.1080/14656566.2016.1195812. Expert Opin Pharmacother. 2016. PMID: 27267933 Review.

10

Brodalumab for the treatment of psoriasis.

Galluzzo M, D'adamio S, Bianchi L, Talamonti M. Galluzzo M, et al. Expert Rev Clin Immunol. 2016 Dec;12(12):1255-1271. doi: 10.1080/1744666X.2016.1246957. Epub 2016 Oct 21. Expert Rev Clin Immunol. 2016. PMID: 27718760 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

43 results

Search Page